Company Filing History:
1 out of 1,829 
1 out of 53 
Years Active: 2007
Title: Srinkanth Venkatraman: Innovator in Hepatitis C Treatment
Introduction
Srinkanth Venkatraman is a notable inventor based in Fords, New Jersey. He has made significant contributions to the field of medical science, particularly in the treatment of hepatitis C virus (HCV). His innovative work has led to the development of novel peptide compounds that have the potential to inhibit HCV protease activity.
Latest Patents
Venkatraman holds a patent for "Peptides as NS3-serine protease inhibitors of hepatitis C virus." This invention discloses novel peptide compounds that exhibit HCV protease inhibitory activity. Additionally, it outlines methods for preparing these compounds and pharmaceutical compositions that include them. The invention also details methods for using these compounds to treat disorders associated with the HCV protease.
Career Highlights
Throughout his career, Venkatraman has worked with prominent companies in the pharmaceutical industry. He has been associated with Schering Corporation and Dendreon Corporation, where he contributed to various research and development projects aimed at advancing medical treatments.
Collaborations
Some of his notable coworkers include Anil K Saksena and Viyyoor Moopil Girijavallabhan. Their collaborative efforts have likely played a role in the success of his innovative projects.
Conclusion
Srinkanth Venkatraman's work in developing peptide compounds for hepatitis C treatment showcases his dedication to advancing medical science. His contributions have the potential to significantly impact the treatment of HCV and improve patient outcomes.